Good News on Listing | Frost & Sullivan Assists Zhejiang Yongtai Technology Co., Ltd. in Successfully Issuing GDRs and Listing on the London Stock Exchange (YTT)

Zhejiang Yongtai Technology Co., Ltd. (hereinafter referred to as "Yongtai Technology") was successfully listed on July 11, 2023. A total of 7.4389 million GDRs were issued this time, with an issue price of $9.41 per GDR, raising approximately $70 million. The A-share shares represented by these GDRs account for 4.07% of the total A-share capital after issuance.

During the process of listing on the London Stock Exchange, Frost & Sullivan mainly undertook the following tasks: helping the issuer accurately and objectively understand its positioning in the target market, using objective market data to discover, support, and highlight the issuer's competitive advantages, assisting the issuer, investment banks, and other intermediaries in completing relevant parts of the prospectus (such as overview, competitive advantages and strategy, industry overview, business, and other important chapters), helping the issuer communicate with the London Stock Exchange and investors, assisting investors in quickly understanding the market ecosystem and competitive landscape, and assisting the issuer in completing feedback on various industry-related issues at the London Stock Exchange.

The company is a manufacturer of fluorinated pharmaceuticals, pesticides, and new energy materials with a complete vertically integrated industrial chain;

The company possesses multiple core technologies, with a wide range of product applications and high added value. It has strong market adaptability and product structure upgrading capabilities.

Global and Chinese Fluorine Chemical Industry Market Size

10 billion USD, forecast from 2017 - 2026

With the rapid development of the new energy industry and strong demand in related lithium battery industries, the development of related lithium battery manufacturing industries has been rapidly driven, presenting a relatively fierce competitive situation among new material producers.

According to the Frost & Sullivan report, calculated by production volume in 2021, the company ranks third among leading lithium hexafluorophosphate (lithium salt) manufacturers in China; calculated by output value in 2021, the company ranks third among leading lithium hexafluorophosphate (lithium salt) manufacturers in China; the company is the manufacturer with the highest annual compound growth rate in three years of lithium hexafluorophosphate (lithium salt) production (note: production capacity above 2,000 tons); the company is the manufacturer with the highest annual compound growth rate in three years of lithium hexafluorophosphate (lithium salt) output value (note: production capacity above 2,000 tons).

Pharmaceutical intermediates refer to intermediate products that have been processed and need further processing before becoming pharmacologically active compounds. Fluorinated organic compounds have strong lipophilicity and hydrophobicity, which can promote their absorption and transfer speed within organisms. Therefore, fluorinated pharmaceuticals have characteristics such as low dosage, low toxicity, high efficacy, and strong metabolic capacity. Pharmaceutical intermediates can be divided into primary pharmaceutical intermediates and advanced pharmaceutical intermediates, with advanced pharmaceutical intermediates often requiring only one or two synthesis steps to make active pharmaceutical ingredients.

Currently, the main applications of fluorinated fine chemicals in medicine include key fluorinated intermediates, pharmaceutical active pharmaceutical ingredients, and preparations. Classified by end application fields, they are divided into antibacterial drugs, vascular drugs, diabetes drugs, central nervous system drugs, anti-infective drugs, antiviral drugs, etc. Fluorides have a wide range of applications and many product types in the pharmaceutical field and are an indispensable key compound material in the pharmaceutical industry.

According to the Frost & Sullivan report, calculated by the output value of fluorinated pharmaceutical intermediates in 2021, the company is the largest manufacturer of fluorinated pharmaceutical intermediates in China; calculated by the cumulative output value from 2019 to 2021 (three years), the company is the largest manufacturer of fluorinated pharmaceutical intermediates in China; calculated by the output value in 2021, the company is the largest manufacturer of fluorinated pharmaceutical fine chemical products in China; calculated by the cumulative output value from 2019 to 2021 (three years), the company is the largest manufacturer of fluorinated pharmaceutical fine chemical products in China.

Fluorinated pesticides have characteristics such as high membrane permeability, anti-metabolic stability, affinity for lipid membranes, thermal stability, and chemical stability. Fluorinated pesticides are very important fluorinated fine chemicals. They have advantages such as high selectivity, high adaptability, high added value, low cost, low toxicity, low residue, and environmental friendliness. They are the trend of contemporary pesticide development. Compared with traditional pesticide products, they have high activity, low toxicity, small per mu dosage, relatively less impact on the environment, use water-based formulations, reduce or do not use aromatic solvents, and increase environmental compatibility.

Fluorinated pesticides are one of the important fields of fine chemicals and have rigid demand. The development technology level of pesticide intermediates is the key to pesticide development, and fluorinated pesticides are one of the focuses of global research and development. In China, the number of pesticide poisoning cases each year accounts for about 50% of the world's total. Controlling pesticide pollution and protecting the ecological environment have become hot topics in environmental protection.

According to the Frost & Sullivan report, calculated by the export output value of fluorinated pesticide intermediates in 2021, the company is the largest export brand of fluorinated pesticide intermediates in China; calculated by the cumulative export output value of fluorinated pesticide intermediates from 2019 to 2021 (three years), the company is the largest export brand of fluorinated pesticide intermediates in China.

Frost & Sullivan has rich research experience in the chemical and materials industries and has assisted well-known enterprises to successfully list on the capital market. Successful listing cases include: Jintai Feng (9689.HK), Zhongbao New Materials (2439.HK), Shengneng Group (2459.HK), Jinli Yongcime (6680.HK), Avia Avian (IDX: AVIA), Global New Materials (6616.HK), Dafeng Equipment (2153.HK), Yihé International (8659.HK), GHW (9933.HK), Sanhe Fine Chemicals (0301.HK), Xingyu Holdings (2346.HK), Xinghe Holdings (1891.HK), Xuyang Group (1907.HK), Long Resources (1712.HK), Shandong Gold (1787.HK), Henan Jinma (6885.HK), Xingye New Materials (8073.HK), Dongguang Chemicals (1702.HK), Zhongqi Group (1932.HK), Xinbang Holdings (1571.HK), Meigu Technology (8349.HK), Huajin International (2738.HK), Fultite Glass (6865.HK), Dinos (1452.HK), Caike Chemicals (1986.HK), Chang'an Renheng (8139.HK), Sansida (1337.TWSE), Born NYSE, CPC NYSE, Gu NYSE, Tianhe Chemicals (1619.HK), Yihua Holdings (2121.HK), Sijia Group (1863.HK), etc.